Back to UBS Group AG UBS Group AG

TLXTLX
7 quarters

Position history for UBS Group AGUBS Group AG's holdings in TELIX PHARMACEUTICAL LTD

UBS Group AG holds 134,698 shares of TLX (TELIX PHARMACEUTICAL LTD), worth $1.6M as of 2026-Q2. The position was increased (+317.0% shares). TLX represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.6M

Current Shares

134,698

Total Value Change

+$1.5M

Total Shares Change

+130,968

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
134,698
+317.0%
$1.6M0.0%$11.53
41
2026-Q1
Increased
32,300
+1544.6%
$309,1110.0%$6.97
26
2025-Q4
Decreased
1,964
-64.7%
$14,7100.0%$7.75
0
2025-Q3
Decreased
5,565
-9.1%
$53,2570.0%$9.89
0
2025-Q2
Increased
6,121
+67.7%
$98,3640.0%$16.00
22
2025-Q1
Decreased
3,651
-2.1%
$61,1910.0%$17.24
0
2024-Q4
New
3,730
-
$57,4420.0%$16.10
32

Other major holders of TLX: FMR LLC, LAZARD ASSET MANAGEMENT LLC, Private Advisor Group, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used